PhRMA Backs Increased FDA Drug Import Controls

Law360, Washington (September 04, 2013, 4:00 PM ET) -- The Pharmaceutical Research and Manufacturers of America will support efforts by the U.S. Food and Drug Administration to prescreen and sort drug importers for additional scrutiny based on risk, similar to the methods used in a recently announced pilot program, according to a comment made public Wednesday.

In PhRMA's comment to the FDA, dated Aug. 12 but only made public Wednesday, the industry advocacy group said it supports efforts by the agency to use the additional authority granted to it under Title VII of last year's...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers